HALO: Halozyme Therapeutics Inc. Stocks News on March 14, 2025

HALO

Zacks

3 days ago

HALO vs. AMGN: Which Stock Is the Better Value Option?

HALO

Insider Monkey

4 days ago

Artisan Small Cap Fund Reduced its Stake in Halozyme Therapeutics (HALO). Here’s Why

AutoZone Stock Can Hold Up Amid Tariffs, Analyst Says. Plus, Chewy, Chesapeake, and More.

HALO

Barrons.com

7 days ago

AutoZone Stock Can Hold Up Amid Tariffs, Analyst Says. Plus, Chewy, Chesapeake, and More.

High Growth Tech Stocks To Watch In US March 2025

HALO

Simply Wall St.

8 days ago

High Growth Tech Stocks To Watch In US March 2025

HALO

MT Newswires

8 days ago

Update: Market Chatter: Merck Faces Patent Dispute Over New Keytruda Version

New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle

HALO

The Wall Street Journal

9 days ago

New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle

HALO

Zacks

9 days ago

Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock

HALO

MT Newswires

9 days ago

Market Chatter: Merck Faces Patent Dispute Over New Keytruda Version

HALO

Argus Research

10 days ago

HALO: What does Argus have to say about HALO?

HALO

MT Newswires

14 days ago

Halozyme Therapeutics Insider Sold Shares Worth $1,260,681, According to a Recent SEC Filing

HALO

PR Newswire

16 days ago

Halozyme to Participate in the TD Cowen 45th Annual Healthcare Conference

HALO

Argus Research

17 days ago

HALO: What does Argus have to say about HALO?

HALO

Zacks

18 days ago

Is Halozyme Therapeutics (HALO) a Solid Growth Stock? 3 Reasons to Think "Yes"

HALO

Zacks

22 days ago

Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock

HALO

Simply Wall St.

22 days ago

Halozyme Therapeutics Full Year 2024 Earnings: Beats Expectations

HALO

Zacks

23 days ago

HALO's Q4 Earnings Beat, Higher Royalties Drive Revenue Growth

HALO

Thomson Reuters StreetEvents

23 days ago

Q4 2024 Halozyme Therapeutics Inc Earnings Call

HALO

GuruFocus.com

23 days ago

Halozyme Therapeutics Inc (HALO) Q4 2024 Earnings Call Highlights: Record Revenue and Strong ...

HALO

Argus Research

24 days ago

HALO: Raising target price to $61.00

HALO

Zacks

24 days ago

Halozyme Therapeutics (HALO) Reports Q4 Earnings: What Key Metrics Have to Say

HALO

Zacks

24 days ago

Halozyme Therapeutics (HALO) Q4 Earnings and Revenues Top Estimates

HALO

Associated Press Finance

24 days ago

Halozyme Therapeutics: Q4 Earnings Snapshot

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90

HALO

Investor's Business Daily

24 days ago

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90

HALO

MT Newswires

24 days ago

Halozyme Therapeutics Q4 Non-GAAP EPS, Revenue Increase

Incyte Stock Sees Relative Strength Rating Rise To 71

HALO

Investor's Business Daily

24 days ago

Incyte Stock Sees Relative Strength Rating Rise To 71

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

HALO

Zacks

25 days ago

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

HALO

Zacks

a month ago

HALO Gears Up to Report Q4 Earnings: Here's What You Should Know

HALO

Zacks

a month ago

Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock

HALO

Zacks

a month ago

Here's How Much You'd Have If You Invested $1000 in Halozyme Therapeutics a Decade Ago

HALO

Insider Monkey

a month ago

Halozyme Therapeutics, Inc. (HALO): A Cheap Biotech Stock to Invest In Now

HALO

Investor's Business Daily

a month ago

Halozyme Stock Climbs Back After 2024 Sneak Peek As Earnings Loom

HALO

Argus Research

a month ago

HALO: Raising target price to $60.00

HALO

PR Newswire

a month ago

Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results

HALO

MT Newswires

a month ago

Halozyme Therapeutics Says Non-Small Cell Lung Cancer Treatment Gets Positive Opinion in Europe

CHMP Issues Positive Opinion for Subcutaneous RYBREVANT®(amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer

HALO

PR Newswire

a month ago

CHMP Issues Positive Opinion for Subcutaneous RYBREVANT®(amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer

HALO

Zacks

a month ago

Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term

High Growth Tech Stocks To Watch In January 2025

HALO

Simply Wall St.

a month ago

High Growth Tech Stocks To Watch In January 2025

HALO

Argus Research

a month ago

HALO: What does Argus have to say about HALO?

HALO

Zacks

a month ago

Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term

HALO

Zacks

2 months ago

Why Halozyme Therapeutics (HALO) is a Top Momentum Stock for the Long-Term

HALO

Zacks

2 months ago

If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now

HALO

Argus Research

2 months ago

HALO: Raising target price to $59.00

BeiGene Stock Meets 80-Plus RS Rating Benchmark

HALO

Investor's Business Daily

2 months ago

BeiGene Stock Meets 80-Plus RS Rating Benchmark

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

HALO

Zacks

2 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

HALO

Zacks

2 months ago

Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines

HALO

Argus Research

2 months ago

HALO: Raising target price to $57.00

BridgeBio Pharma Stock Earns 87 RS Rating

HALO

Investor's Business Daily

2 months ago

BridgeBio Pharma Stock Earns 87 RS Rating

5 Biotech Stocks Worth Adding to Your Portfolio in 2025

HALO

Zacks

2 months ago

5 Biotech Stocks Worth Adding to Your Portfolio in 2025

PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales

HALO

Zacks

2 months ago

PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales

HALO

Zacks

2 months ago

Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why

SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data

HALO

Zacks

2 months ago

SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

HALO

Zacks

2 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

HALO

Zacks

2 months ago

HALO Raises 2025 Financial Guidance, Keeps 2024 View, Stock Up

HALO

Zacks

2 months ago

Are Options Traders Betting on a Big Move in Halozyme (HALO) Stock?

HALO

Zacks

2 months ago

Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today

SpringWorks Therapeutics Stock Gets A RS Rating Lift

HALO

Investor's Business Daily

2 months ago

SpringWorks Therapeutics Stock Gets A RS Rating Lift

HALO

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise Premarket Wednesday

HALO

MT Newswires

2 months ago

Sector Update: Health Care

HALO

MT Newswires

2 months ago

Halozyme Therapeutics Raises 2025 Guidance; Shares Up Pre-Bell

HALO

PR Newswire

2 months ago

Halozyme Reiterates 2024 Financial Guidance and Raises 2025 and Multi-Year Financial Guidance

HALO

MT Newswires

2 months ago

Halozyme Therapeutics Insider Sold Shares Worth $500,060, According to a Recent SEC Filing

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

HALO

Zacks

2 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

HALO

Zacks

2 months ago

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks

HALO

Zacks

2 months ago

Zacks.com featured highlights include Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical

These 4 Stocks Boast Impressive Interest Coverage Ratios

HALO

Zacks

2 months ago

These 4 Stocks Boast Impressive Interest Coverage Ratios

HALO

PR Newswire

2 months ago

Halozyme to Host Investor Conference Call to Provide Updated 2025 Financial Guidance

Exploring 3 Prominent High Growth Tech Stocks In The United States

HALO

Simply Wall St.

2 months ago

Exploring 3 Prominent High Growth Tech Stocks In The United States

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

HALO

Zacks

2 months ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

HALO

PR Newswire

2 months ago

Halozyme Announces Takeda Received Regulatory Approval for HYQVIA® 10% Subcutaneous Injection Set with ENHANZE® in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia

HALO

PR Newswire

2 months ago

Halozyme Announces argenx's VYDURA with ENHANZE® was Granted Regulatory Approval in Japan for Chronic Inflammatory Demyelinating Polyneuropathy

HALO

PR Newswire

2 months ago

Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig™ with ENHANZE® for Subcutaneous Use in Most Previously Approved Adult Solid Tumor Opdivo® (nivolumab) Indications

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

HALO

Zacks

3 months ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

HALO

Argus Research

3 months ago

HALO: Lowering target price to $58.00

HALO

Zacks

3 months ago

3 Reasons Growth Investors Will Love Halozyme Therapeutics (HALO)

HALO

Zacks

3 months ago

HALO or FOLD: Which Is the Better Value Stock Right Now?

HALO

Argus Research

3 months ago

HALO: Lowering target price to $60.00

HALO

Zacks

3 months ago

How Much Upside is Left in Halozyme Therapeutics (HALO)? Wall Street Analysts Think 27.08%

HALO

Zacks

3 months ago

If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now

HALO

Zacks

3 months ago

Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy?

HALO

Argus Research

3 months ago

HALO: Raising target price to $61.00

HALO

Zacks

3 months ago

Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock

HALO

Zacks

3 months ago

Is Halozyme Therapeutics (HALO) Stock Undervalued Right Now?

HALO

Zacks

3 months ago

Here is Why Growth Investors Should Buy Halozyme Therapeutics (HALO) Now

HALO

Zacks

3 months ago

HALO vs. FOLD: Which Stock Is the Better Value Option?

HALO

Zacks

3 months ago

Is Halozyme Therapeutics (HALO) Outperforming Other Medical Stocks This Year?

HALO

Argus Research

3 months ago

HALO: Rating increased to a BUY

Exploring Three High Growth Tech Stocks in the United States

HALO

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks in the United States

HALO

PR Newswire

4 months ago

Halozyme to Present at Upcoming Investor Conferences

HALO

Argus Research

4 months ago

HALO: Rating decreased to a HOLD

HALO

Zacks

4 months ago

HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up

HALO

MT Newswires

4 months ago

Sector Update: Health Care Stocks Rise Friday Afternoon

HALO

Benzinga

4 months ago

Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook

HALO

Zacks

4 months ago

Halozyme Therapeutics (HALO) Upgraded to Buy: Here's Why

HALO

Zacks

4 months ago

Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term

HALO

Investing.com

4 months ago

Halozyme shares jump 12% as it scraps $2.1 bln Evotec deal

HALO

MT Newswires

4 months ago

Sector Update: Health Care Stocks Advance Premarket Friday

HALO

MT Newswires

4 months ago

Update: Halozyme Therapeutics Withdraws Proposal to Acquire Evotec

HALO

MT Newswires

4 months ago

Sector Update: Health Care

HALO

Zacks

4 months ago

Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock

HALO

Zacks

4 months ago

Latest Halozyme Therapeutics Inc. (HALO) News on March 14, 2025

Share on Social Networks: